SCHEMBL457546

SCHEMBL457546

CCOc1c(N)ccc(N)c1NC(C)=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.51
CYP1A2 P05177 3/20 0.47
KMT2A Q03164 3/20 0.47
MEN1 O00255 2/20 0.47
LMNA P02545 1/20 0.47
MAPT P10636 3/20 0.44
MAPK8 P45983 2/20 0.42
CYP2C9 P11712 2/20 0.41
CYP2C19 P33261 1/20 0.41
RORC P51449 1/20 0.41
PRKD3 O94806 1/20 0.41
MAP4K4 O95819 1/20 0.41
MAPK9 P45984 1/20 0.41
MAPK10 P53779 1/20 0.41
MAP4K2 Q12851 1/20 0.41
PKN2 Q16513 1/20 0.41
PRKD2 Q9BZL6 1/20 0.41
STK17A Q9UEE5 1/20 0.41
CREBBP Q92793 1/20 0.41
RAB9A P51151 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2336609 0.74 TDP1 (0.78) TDP1CYP1A2KMT2AMEN1LMNA
SCHEMBL27572770 0.73 KDM4E (0.49) TDP1CYP1A2KMT2AMEN1LMNA
SCHEMBL27571353 0.73 MAPT (0.52) TDP1CYP1A2KMT2AMEN1LMNA
SCHEMBL27640819 0.72 MAPK8 (0.52) TDP1CYP1A2KMT2AMEN1LMNA
SCHEMBL19302733 0.72 MAPT (0.48) TDP1CYP1A2KMT2AMEN1LMNA
SCHEMBL27772170 0.71 CREBBP (0.45) TDP1KMT2AMEN1LMNAMAPT
SCHEMBL11330858 0.70 MAPT (0.55) TDP1CYP1A2KMT2AMEN1LMNA
SCHEMBL30360237 0.70 TDP1 (0.67) TDP1CYP1A2KMT2AMEN1LMNA
SCHEMBL28977416 0.70 TDP1 (0.67) TDP1CYP1A2KMT2AMEN1LMNA
SCHEMBL11322900 0.69 TDP1 (0.47) TDP1CYP1A2KMT2AMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030172471-A1 1,3-diamino-4-(aminomethyl) - benzene derivatives and colorants containing the said compounds HFC PRESTIGE INTERNATIONAL OPERATIONS SWITZERLAND SÀRL (CH) 2003-09-18 US claimed
EP-4452214-A1 COMPOSITION FOR KERATIN FIBERS L'OREAL (FR) 2024-10-30 EP disclosed
WO-2023228870-A1 COMPOSITION FOR COLORING KERATIN FIBERS L'OREAL (FR) 2023-11-30 WO disclosed
EP-4240311-A1 COMPOSITION FOR KERATIN FIBERS L'OREAL (FR) 2023-09-13 EP disclosed
WO-2023106218-A1 COMPOSITION FOR KERATIN FIBERS L'OREAL (FR) 2023-06-15 WO disclosed
CN-113795435-B Soluble package of pre-measured powdered hair bleach 莱雅公司 2023-04-25 CN disclosed
WO-2022097742-A1 COMPOSITION FOR KERATIN FIBERS L'OREAL (FR) 2022-05-12 WO disclosed
WO-2022075204-A1 COMPOSITION FOR KERATIN FIBERS L'OREAL (FR) 2022-04-14 WO disclosed
EP-3233030-A1 COMPOSITION IN THE FORM OF O/W EMULSION L'OREAL (FR) 2017-10-25 EP disclosed
WO-2016098786-A1 COMPOSITION IN THE FORM OF O/W EMULSION L'OREAL (FR) 2016-06-23 WO disclosed
WO-2012032673-A1 COSMETIC COMPOSITION FOR KERATIN FIBERS L'OREAL (FR) 2012-03-15 WO disclosed
WO-2011027077-A2 COMPOSITION COMPRISING A HYDROPHOBIC DYE, A SPECIFIC MINERAL AND/OR ORGANIC ALKALINE AGENT, A SPECIFIC COMPOUND (I) AND A SPECIFIC ORGANIC COMPOUND (II), AND USE THEREOF IN DYEING L'OREAL (FR) 2011-03-10 WO disclosed
WO-2011027076-A2 DYEING METHOD CONSISTING IN APPLYING A METALLIC SALT AND A COMPOSITION CONTAINING A HYDROPHOBIC DYE AND A SPECIFIC COMPOUND L'OREAL (FR) 2011-03-10 WO disclosed
EP-1496849-A1 COMPOSITION FOR THE OXIDATION DYEING OF HUMAN KERATINOUS FIBRES L'OREAL (FR) 2005-01-19 EP disclosed
EP-1458338-A2 DYEING COMPOSITION FOR KERATINOUS FIBERS COMPRISING AN OXYETHYLENE RAPESEED FATTY ACID AMIDE L'OREAL (FR) 2004-09-22 EP disclosed
WO-2003084495-A1 COMPOSITION FOR THE OXIDATION DYEING OF HUMAN KERATINOUS FIBRES L'OREAL (FR) 2003-10-16 WO disclosed
WO-2003053329-A2 DYEING COMPOSITION FOR KERATINOUS FIBERS COMPRISING AN OXYETHYLENE RAPESEED FATTY ACID AMIDE L'OREAL (FR) 2003-07-03 WO disclosed
US-6579326-B2 For dyeing hair L'OREAL S.A. (FR) 2003-06-17 US disclosed
US-20030028975-A9 COMPOSITIONS FOR DYEING KERATIN FIBERS, CONTAINING CATIONIC INDOLIZINE DERIVATIVES, AND DYEING PROCESS L'OREAL S.A. (FR) 2003-02-13 US disclosed
US-20010044974-A1 Compositions for dyeing keratin fibers, containing cationic indolizine derivatives, and dyeing process BRETON PHILIPPE (FR) 2001-11-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010044974-A1 Compositions for dyeing keratin fibers, containing cationic indolizine derivatives, and dyeing process KRT18, INMT, KMO TDP1 2965/4885CYP1A2 2076/4885KMT2A 1057/4885
US-20030172471-A1 1,3-diamino-4-(aminomethyl) - benzene derivatives and colorants containing the said compounds AOC1, DPYD, NDUFB4 TDP1 264/4885CYP1A2 591/4885KMT2A 3305/4885
US-20030028975-A9 COMPOSITIONS FOR DYEING KERATIN FIBERS, CONTAINING CATIONIC INDOLIZINE DERIVATIVES, AND DYEING PROCESS KRT18, INMT, KMO TDP1 3046/4885CYP1A2 2082/4885KMT2A 1086/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.